Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(9%)
Results Posted
33%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
1
9%
Ph phase_4
1
9%
Ph not_applicable
5
45%
Ph phase_2
4
36%

Phase Distribution

0

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)
Other(3)

Detailed Status

Completed6
unknown3
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (36.4%)
Phase 31 (9.1%)
Phase 41 (9.1%)
N/A5 (45.5%)

Trials by Status

terminated19%
unknown327%
completed655%
recruiting19%

Recent Activity

1 active trials
Showing 5 of 11
recruitingphase_2

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

NCT02605421
completedphase_4

Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer

NCT03945812
completednot_applicable

High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

NCT01526603
terminatednot_applicable

G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome

NCT00228813
completedphase_3

To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis

NCT02642003
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT02605421Phase 2

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

Recruiting
NCT03945812Phase 4

Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer

Completed
NCT01526603Not Applicable

High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

Completed
NCT00228813Not Applicable

G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome

Terminated
NCT02642003Phase 3

To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis

Completed
NCT00231309Not Applicable

Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)

Completed
NCT01825551Phase 2

The Effect of GCSF in the Treatment of ALS Patients

Completed
NCT01341951Not Applicable

Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis

Unknown
NCT01036932Not Applicable

Granulocyte Colony Stimulating Factor(G-CSF) Therapy for Patients With ACLF

Unknown
NCT00397423Phase 2

G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response

Completed
NCT00394498Phase 2

Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair

Unknown

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11